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                                       1.    INTRODUCTION 
   The perioperative period is usually associated with a variety of 
pathophysiologic responses that are initiated  or maintained by nociceptive 
input. Uncontrolled postoperative pain may produce various acute and chronic 
effects which may be detrimental to the patient. 
        The  perioperative  pathophysiological changes that occurs during surgery 
can be attenuated through reduction of transmission of nociceptive input to the 
central nervous system by providing  perioperative analgesia. This also 
- Decreases complications, 
-Facilitate recovery during the immediate postoperative period, 
-Improves long term recovery, 
-Reduces the length of hospital stay, 
-Improves the  quality of life.
(1)
 
     Post operative pain management should be planned and tailored to the needs 
of special population like ambulatory surgical patient, elderly, paediatric, opioid 
tolerant, obese patients and those with obstructive sleep apnea syndrome. 
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IMMEDIATE  EFFECTS OF POSTOPERATIVE  PAIN: 
     Transmission of nociceptive stimuli from the periphery to the Central 
nervous system results in the neuroendocrine stress response, a combination of 
local inflammatory substances (eg.cytokines, prostaglandins, leukotrienes, 
tumor necrosis factor-α) and systemic mediators of the neuroendocrine 
response. 
      Suprasegmental reflex response to pain results in increased sympathetic 
tone, increased catecholamine levels, increased catabolic hormone secretion and 
decreased secretion of anabolic hormones which results in  sodium and water 
retention , increased levels of blood glucose, free fatty acids, ketone bodies and 
lactate. 
       A hypermetabolic state occurs as metabolism and oxygen consumption are 
increased. The extent of the stress response is influenced by following factors: 
 the type of anesthesia,  
 the degree of surgical trauma. 
     The stress response may lead to postoperative hypercoagulability. 
Enhancement of coagulation, inhibition of fibrinolysis, increased platelet 
reactivity and plasma viscosity may contribute to an increased incidence of 
postoperative hypercoagulablility related events such as deep venous 
thrombosis, vascular graft failure and myocardial ischemia. The stress response 
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also potentiate postoperative immunosuppression, the extent of which correlates 
with the severity of surgical injury. 
      Sympathetic activation may increase myocardial oxygen consumption,  
decrease myocardial oxygen supply through coronary vasoconstriction and 
attenuation of local metabolic coronary vasodilation.
 
      Activation of the sympathetic nervous system also delays return of 
postoperative gastrointestinal motility, which may develop into paralytic ileus
(2)
 
       Postoperative respiratory function is markedly decreased, especially after 
upper abdominal and thoracic surgery. Reflex inhibition of phrenic nerve 
activity is an important component of this decreased postoperative pulmonary 
function. Patients with poor pain control may breathe less deeply, have an 
inadequate cough, and more susceptible to the development of postoperative 
pulmonary complications. 
DELAYED EFFECTS OF POSTOPERATIVE PAIN: 
        Chronic postsurgical pain [CPSP] is a largely unrecognized problem that 
may occur in 10% to 65% of postoperative patients. Poorly controlled acute 
postoperative pain may be an important predictive factor in the development of 
CPSP. The transition from acute to chronic pain occurs very quickly and  
longterm behavioral and neurobiologic changes occur much earlier than was 
previously thought. 
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     CPSP is relatively common after procedures such as limb amputation (30% 
to 83%), thoracotomy (22% to 67%), sternotomy (10 to 27%), and breast 
surgery (11% to 57%). 
      Traditionally various techniques and drugs have been adopted for 
postoperative analgesia. These include regional techniques like epidural 
analgesia with local anesthetics alone or opioid alone or combination of both, 
peripheral blocks, NSAIDS, parenteral opioids, non epidural analgesia like 
intrapleural analgesia, paravertebral block, intra articular analgesia etc. 
Epidural steroids have been used successfully for long time for chronic pain 
syndrome. The safety of epidural steroids is well established. Based on the 
above evidences and concepts in this study we used dexamethasone epidurally 
to study the effects on acute postoperative pain. 
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     HISTORY OF EPIDURAL ANESTHESIA & ANALGESIA 
                                                           
 Jean Enthuse Sicard (1872-1929) and Fernand Cathelin (1873-1945) 
independently introduced cocaine through the sacral hiatus in 1901 
,thereby becoming the first practitioners of caudal (epidural) anesthesia.  
 Sicard - a neurologist, used the technique to treat sciatica and tabes, but 
Cathelin used the technique for surgical anesthesia. 
 Arthur Läwen (1876-1958)- an early proponent of regional anesthesia, 
successfully used caudal anesthesia with large volumes of procaine for 
pelvic surgery. 
 Heile - published an extensive study of the epidural space in 1913. His 
unique approach was to enter the epidural space through the intervertebral 
foramina. 
 In 1921, Fidel Pagés (1886-1923), a Spanish military surgeon- devised a 
technique to introduce epidural procaine at all levels of the neuraxis. His 
method was to use a blunt needle and then feel and hear entry of the 
needle through the ligamentum flavum. 
 An important innovation was Dogliotti's method of identification of the 
epidural space. His textbook illustrates the use of continuous pressure on 
the plunger of a saline filled syringe as the needle is advanced through the 
ligamentous structures.  
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 Gutierrez of Argentina  developed the “hanging drop” sign, which is still 
used by some anesthesiologists to identify the epidural space. William T. 
Lemmon (1896-1974) used a 17-gauge, malleable,  silver needle that was 
connected through a hole in the operating room table to rubber tubing and 
a syringe.  
 Edward B. Tuohy (1908-1959) used a ureteral catheter threaded through a 
large Huber-tipped spinal needle to provide continuous spinal anesthesia.  
 Behar in 1979 first reported the use of epidural morphine for treatment of 
pain. 
 Robecchi and Capra in 1952 treated radiculopathy with periradicular 
hydrocortisone. It is the first documented use of epidural steroids . 
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                            2. ANATOMY OF EPIDURAL SPACE 
        Everything outside the dural sac but within the vertebral canal can be   
considered to constitute the epidural space. 
  Boundaries of epidural space: 
 The walls of vertebral canal including the vertebral bodies and discs 
anteriorly 
 Pedicles laterally 
 Lamina and ligamentum flava posteriorly 
        Epidural space is a potential space normally contains  – fat, vessels and 
nerves. The cranial epidural space is entirely empty. The epidural fat which is 
nearly fluid in texture permits gliding movement of the neural structures and 
provides a padding effect. The distribution of epidural contents is highly non 
uniform. 
  Separated  by these empty areas, the epidural contents occur as a series of 
metamerically and circumferentially discontinuous compartments. In contrast to 
this below L4, the dural sac tapers resulting in complete filling of epidural fat. 
Thus there will be difficulty in delivering local anaesthetic to the L5 and sacral 
nerve roots during epidural anaesthesia, since solution is not confined in close 
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proximity with neural structures at these levels. 
 
 Posterior epidural compartment: 
 A triangular part of fat pad fills the dura posterior to epidural space. It is 
enclosed by ligamentum flava but also extends under the caudal most portion of 
lamina above. The largest posterior epidural compartment is at the mid lumbar 
level with progressive decrease in anteroposterior dimension at thoracic 
levels
(3)
. Rostral to C7 level the posterior epidural space vanishes and the 
posterior dura lies in contact with the ligamentum flavum and the laminar bone. 
      A cleft like space between epidural fat and the canal wall allows passage of 
catheters and injected fluids with only a minor impediment in posterior midline. 
This arrangement of opposing non adherent tissue plane is ideally designed to 
demonstrate the normal subatmospheric pressure within tissues, generated by 
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the usual action of lymphatics and the balance of osmotic and hydrostatic forces 
across the capillary endothelium. 
Lateral epidural compartment: 
         No epidural contents exist lateral to the dural sac where it is in contact 
with the vertebral pedicles. This compartment forms just medial to each 
intervertebral foramen and is filled with segmental nerves, vessels and fat.  
         The pressure in the epidural space closely reflects abdominal pressure 
because of the flexibility of tissues and lack of rigid barrier. Increased 
abdominal pressure such as during a cough or pregnancy is therefore readily 
transmitted to the epidural space. 
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Anterior epidural space: 
  The anterior epidural compartment is separated from rest of vertebral 
column by fascia of posterior longitudinal ligament. The spread of injected drug 
anterior to plane of posterior longitudinal ligament is effectively blocked by this 
membrane.At the level of the narrow mid portion of the vertebral body this is 
almost occupied by internal vertebral plexus. Catheters that transgress into the 
anterior epidural space through the fascia of the posterior longitudinal ligament 
are likely to enter the venous plexus. 
Functional implications of epidural space: 
         The spread of injected solutions is circumferential at a given level and 
passes out of the intervertebral foramen and likewise freely passes 
longitudinally within the vertebral canal.  
        As the catheter is advanced through the needle, there may be a brief 
resistance to advancement as the tip encounters the dura. CT scan shows that 
catheter tip inserted 3 cm into the vertebral canal most commonly travel 
laterally to the internal aspect of an intervertebral foramen because of the 
stiffness of the short segment of catheter that has emerged from the needle.  
Even when the catheter tip lies exterior to the intervertebral foramina in the 
paravertebral space, the distribution of the injected solution is preferentially 
back into the vertebral canal . 
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            PHYSIOLOGICAL EFFECTS OF EPIDURAL BLOCKADE 
 Epidural neural blockade implies sympathetic blockade accompanied by 
somatic blockade in the form of sensory and motor blockade alone or in 
combination. 
CARDIOVASCULAR EFFECTS: 
  Blockade of sympathetic innervation accounts for the cardiovascular 
responses. Preganglionic sympathetic innervation – regulates regional blood 
flow. Post ganglionic sympathetic innervations – controls cardiac function and 
vascular tone. Peripheral sympathetic blockade causes vascular dilatation in 
pelvis and lower limbs  when lower thoracic and lumbar segments are blocked 
with epidural anaesthesia. 
      Cardiovascular depression is atleast partly related to the level of sympathetic 
blockade. Vascular absorption of local anaesthetic and addition of 
vasoconstrictor may result in significant hemodynamic changes after epidural 
but not after subarachnoid blockade. 
      Lumbar epidural anaesthesia with sympathetic blockade below T10 results 
in minimal vasodilatory consequences because fewer vasoconstrictor fibres are 
included and neither the sphlanchnic nerves nor the nerve supply to the adrenal 
medulla are affected. Since muscle veins lack sympathetic innervation, 
venodilatation of the extremities is limited to skin and so minimal capacitance 
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increase results from blocks of the lower extremities
.(4)
.Lumbar epidural 
anesthesia with a sympathetic blockade extending to the lower segments may 
occasionally be associated with profound bradycardia and circulatory collapse 
without any obvious precipitating event. 
 RESPIRATORY EFFECTS: 
Following aspects may influence respiration.  
 sensory neural blockade reduces nociceptive afferent drive to respiratory     
center. 
 motor neural blockade of intercostals muscles, abdominal muscles and 
diaphragm. 
 sympathetic neural blockade with resultant change in cardiac output . 
 vagal dominance. 
       The potential for phrenic nerve palsy is rare with epidural block. 
Respiratory arrest is rare and commonly associated with extensive sympathetic 
blockade, reduced cardiac output and reduced oxygen to the CNS. In patients 
with severe pain epidural block probably improves Vital capacity and 
Functional residual capacity as well as PaO2. Thoracic epidural anesthesia does 
not impair the hypoxic drive. The inhibitory reflex of phrenic nerve motor drive 
is interrupted with thoracic epidural anesthesia resulting in increased 
diaphragmatic activity .  
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NEUROENDOCRINE EFFECTS OF EPIDURAL BLOCKADE: 
       Most of the surgically induced endocrine and metabolic changes are 
abolished by an appropriate level of sensory blockade produced by regional 
anesthesia. Surgical stress responses during major upper abdominal and thoracic 
procedures are not effectively amileorated by epidural anaesthesia due to 
incomplete blockade of nociceptive pathways. Sympathetic block abolishes the 
increase in renin activity in response to arterial hypotension. Vasopressin 
system is activated in response to hypotension 
 EPIDURAL BLOCKADE AND MOTOR FUNCTION: 
 The degree of motor blockade increases as dose of drug increases. Usage of 
dilute concentration of local anesthetics facilitates ultra early ambulation. Motor 
blockade in lower limbs is assessed by bromage scale. 
BROMAGE SCALE:  
No block (0%) Full flexion of knees and feet possible 
Partial (33% ) Just able to flex knees, still full flexion 
of feet possible 
Almost complete( 66%) Unable to flex knees, still flexion of 
feet 
Complete (100%)  Unable to move legs or feet 
Table 1 showing assessment of motor blockade in lower limb 
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RECTUS ABDOMINIS MUSCLE (RAM) TEST: 
This is useful in abdominal surgery, when abdominal muscle blockade is 
required rather than lower limb muscle blockade.
(5) 
100% power Able to rise from supine to sitting 
position with hands behind head 
80% power Can sit only with arms extended 
60% power Can lift only head and scapula off bed 
40% power Can lift only shoulders off bed 
20% power An increase in abdominal muscle 
tension can be felt during effort; no 
other response 
Table 2 showing assessment of motor blockade of abdominal muscles. 
THERMOREGULATION AND SHIVERING: 
     Hypothermia is common in patients undergoing surgery with epidural 
anesthesia and it results from heat loss to the cold environment due to 
sympathectomy induced vasodilatation and in part from redistribution of heat 
from central to peripheral regions.  
       Pregnancy may enhance the contribution of spinal thermoregulatory input. 
Injection of epidural pethidine 25mg or epidural fentanyl 50 µg abolishes 
shivering from epidural local analgesia.  
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EFFECTS ON GIT: 
     Epidural block extending from T6 to L1 effectively denervates the 
sphlanchnic sympathetic supply to the abdominal viscera. As a result 
parasympathetic activity predominates resulting in contraction of gut. Thoracic 
epidural anesthesia with local anaesthetics shortens the duration of 
postoperative paralytic ileus. Unopposed parasympathetic activity with 
blockade of afferent nociceptive and thoracolumbar efferents  produces a 
shortened postoperative colonic ileus. 
     Epidural anesthesia have protective action on gut due to improved mucosal 
blood flow. This increase in blood flow may contribute to the healing of gut 
anastomosis. Epidural anesthesia with local anaesthetic seems to be the best 
method for relieving pain after gastrointestinal surgery. 
EFFECTS ON  BLOOD LOSS: 
      Patients receiving epidural block had operative blood losses that were half 
those associated with general anaesthesia. Blood loss can be reduced as far as  
30 to 40 % if epidural block is used for hip surgery. Factors that reduce blood 
loss include mild reduction in arterial blood pressure, increase in venous 
capacitance, prevention of high venous pressure in response to sympathetic 
activity resulting from pain and use of appropriate position. 
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EPIDURAL ANESTHESIA & ANALGESIA 
Epidural anesthesia is a central neuraxial block technique which provides 
segmental blockade. Improvements in equipment, drugs and technique have 
made it a popular and versatile anesthetic technique, with applications in 
surgery, obstetrics and pain control. Its versatility means it can be used as an 
anesthetic, as an analgesic adjuvant to general anesthesia, and for 
postoperative analgesia in procedures involving the lower limbs, perineum, 
pelvis, abdomen and thorax. 
General indications: 
Epidural anesthesia can be used as sole anesthetic for procedures 
involving the lower limbs, pelvis, perineum and lower abdomen. It is possible 
to perform upper abdominal and thoracic procedures under epidural 
anesthesia alone, but the height of block required, with its attendant side 
effects, make it difficult to avoid significant patient discomfort and risk. 
 The advantage of epidural over spinal anesthesia is the ability to 
maintain  continuous anesthesia after placement of an epidural catheter, thus 
making it suitable for procedures of long duration. This feature also enables 
the use of this technique into the postoperative period for analgesia, using 
lower concentrations of local anaesthetic drugs or in combination with 
different agents. 
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Specific indications: 
Hip and knee surgery: Internal fixation of a fractured hip is associated with 
less blood loss when central neuraxial block is used. The rate of deep venous 
thrombosis is reduced in patients undergoing total hip and knee replacement, 
when epidural anaesthesia is used. 
Vascular reconstruction of the lower limbs: Epidural anesthesia improves 
distal blood flow in patients undergoing arterial reconstruction surgery. 
Amputation: Patients given epidural anaesthesia 48-72 hours prior to lower 
limb amputation may have a lower incidence of phantom limb pain following 
surgery. 
Thoracic trauma with rib or sternum fractures: Adequate analgesia in 
patients with thoracic trauma improves respiratory function by allowing the 
patient to breathe adequately, cough and cooperate with chest physiotherapy.  
Obstetrics:  Epidural analgesia is indicated in obstetric patients in difficult or 
high-risk labour.Caesarean section performed under central neuraxial block is 
associated with a lower maternal mortality and better perioperative outcome.  
CONTRAINDICATION OF EPIDURAL ANESTHESIA: 
ABSOLUTE: 
 Patient refusal 
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 Infection at the site of injection 
 Coagulopathy or other bleeding diathesis 
 Severe hypovolemia 
 Increased intracranial pressure 
 Severe stenotic valvular  heart disease with low fixed cardiac output 
syndrome. 
 Severe hypotension 
 Known allergy to local anesthetics 
RELATIVE: 
 Sepsis 
 Uncooperative patient 
 Pre-existing neurological disease 
 Severe spinal deformities  
 Patients on anticoagulants. 
ADVANTAGES: 
 Use of perioperative epidural anesthesia and analgesia, especially with a 
local anesthetic–based analgesic solution, can attenuate the 
pathophysiologic response to surgery and may be associated with a 
reduction in mortality and morbidity when compared with analgesia with 
systemic opioid agents.
 
Use of epidural analgesia can decrease the 
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incidence of postoperative gastrointestinal, pulmonary, and possibly 
cardiac complications by inhibiting sympathetic outflow, decreasing the 
total opioid dose, and attenuating spinal reflex inhibition of the 
gastrointestinal tract. 
 Postoperative thoracic epidural analgesia can facilitate return of 
gastrointestinal motility without contributing to anastomotic bowel 
dehiscence. Patients who receive epidural local anesthetics have an earlier 
return of gastrointestinal motility after abdominal surgery.  
 Perioperative use of epidural analgesia with a local anesthetic–based 
regimen in patients undergoing abdominal and thoracic surgery decreases 
postoperative pulmonary complications, presumably by preserving 
postoperative pulmonary function by providing superior analgesia and 
thus reducing splinting behavior and attenuating the spinal reflex 
inhibition of diaphragmatic function. 
 Use of postoperative thoracic, but not lumbar epidural analgesia may 
decrease the incidence of postoperative myocardial infarction
(12)
,possibly 
by attenuating the stress response hypercoagulability, improving 
postoperative analgesia and providing favorable redistribution of 
coronary blood flow.  
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FACTORS AFFECTING EPIDURAL BLOCKADE: 
SITE OF INJECTION AND NERVE ROOT SIZE: 
Injection of drug close to nerve roots results in rapid and intense 
blockade. After lumbar epidural injection, a somewhat greater cranial than 
caudal spread of analgesia occurs. The spread of analgesia is even when drugs 
are injected in midthoracic epidural injection. 
 Concentration of large number of nerve fibres within upper thoracic and 
cervical segments makes them resistant to blockade with epidural injections. 
Caudal epidural block spreads from S5 and the S1 segment is the last to be 
blocked. 
VOLUME: 
Segmental dose is the spread of the volume of anesthetic solution injected in ml 
per no of dermatomes blocked. The capacity of lower part of epidural space is 
larger. For each pair of segment the following dose is recommended: 
For cervical region – 1.5 ml 
For thoracic region – 2 ml 
For lumbar region -   2.5 ml 
The per segment volume of anesthetic solution necessary in sacral and lower 
lumbar region is greater. For single injection technique the dose should range 
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from 15 – 20 ml of anesthetic solution. For continous technique the initial dose 
is 8 – 12 ml and subsequently 5 – 7 ml every hour. 
AGE: 
In the elderly, the areolar tissue around the intervertebral foramina becomes 
dense and firm partially sealing the foramina. The permeability of duramater 
increases with increase in age. Aging is associated with reduced beta adrenergic 
responsiveness. Increased levels of analgesia with increase in age is due  : 
 Progressive sclerosis of intervertebral foramina results in reduced                         
leakage of injected solutions into paravertebral space. 
 Increased permeability of duramater. 
 Increased compliance of the epidural space. 
 Decreased resistance of epidural space. 
   With aging neural population declines steadily within the spinal cord and 
peripheral nerves show a linear reduction in conduction velocity especially 
motor nerves. These changes makes older patients more sensitive to local  
anesthetics with altered motor block profile. 
    Thermoregulatory response declines with age as shown by decrease in core 
temperature consequently rewarming process will occur more slowly in elder 
patients. 
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CONCENTRATION AND DOSE OF LOCAL ANAESTHETIC: 
      Below concentrations of 1% lignocaine motor block is minimal regardless 
of dose, unless injections are repeated at intervals. When dilute solutions in 
concentration of 0.125% or 0.625% bupivacaine are injected repeatedly the 
intensity of sensory and motor blockade increase. This mechanism is 
particularly important in obstetric analgesia. Increasing concentration results in 
reduction in onset time yet produces intense motor blockade.  
DRUG CLINICAL 
USE 
CONCENTRATION 
         ( % ) 
DURATION(min) 
Lignocaine infiltration 0.5  60 - 240 
 Peripheral 
blocks 
1 60 – 200 
 epidural 1.5 - 2 60 - 120 
spinal 2 - 5 30 - 60 
Bupivacaine infiltration 0.25 120 - 480 
 epidural 0.5  120 - 300 
spinal 0.5  60 - 240 
Ropivacaine infiltration 0.2 – 0.5 120 - 360 
 epidural 0.5 - 1 120 - 360 
spinal 0.5 – 0.75 90 - 200 
Table 3 showing concentration of commonly used drugs. 
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If more potent analgesia with minimal motor block is required 0.5% 
bupivacaine, 0.5%  ropivacaine, 0.5%  levobupivacaine or 1% lignocaine may 
be chosen. The requirement of profound sensory block and excellent muscle 
relaxation are best met by 1% lignocaine with epinephrine or 0.75% to 1% 
ropivacaine.  The toxic plasma concentration of lignocaine, bupivacaine, 
ropivacaine were >5, > 3, >4 ng / ml respectively. 
 POSITION OF THE PATIENT: 
     Comparison of sitting and lateral position for epidural block reveals no 
significant differences in cephalad spread. An exception is the obese patient 
who achieves a lower level of block when seated. The spread of analgesia is 
more intense in dependent portion when drugs injected in lateral position in 
both pregnant and non pregnant women. Motor and sensory block onset will be 
rapid in the dependent portion. 
SPEED OF INJECTION: 
      Rapid injection of local anesthetics into epidural space has no effect on 
spread of analgesia and has only minimal effect on bulk flow of solution in the 
space. Rapid injections of large volumes of solution may increase CSF pressure, 
decreases spinal cord blood flow, increase intracranial pressure and pose a risk 
of spinal or cerebral complications. Headache is commonly reported if epidural 
solutions are rapidly injected.  
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NUMBER & FREQUENCY OF LOCAL ANESTHETIC INJECTIONS: 
      A single  repeat dose (20% of total dose) given approximately 20 minutes 
after the main dose of local anaesthetic has been said to consolidate blockade 
within the level of blockade already established. Thus missed segments may be 
filled in but the level of blockade may not be extended.  A second dose of 
approximately 50% of initial dosage will maintain the initial segmental level of 
analgesia if given when the upper level of segmental analgesia has receded 1 to 
2 dermatomes.  In addition tachyphylaxis increases with the number of 
injections especially when short acting amides are used. 
 ADJUVANTS: 
EPINEPHRINE: 
When freshly prepared epinephrine in a concentration of 1:2,00,000 is added to 
the local anaesthetic solution , it 
 Improves the quality of sensory block. 
 Increases the duration and intensity of motor blockade. 
 Enhancement of analgesia seen with epinephrine is due to activation of dorsal 
horn inhibitory system via α 2 adreno receptor and to some extent through 
decreased vascular absorption.  
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CLONIDINE: 
It is a selective α 2 adrenergic agonist which acts by opening potassium 
channels. Prolongs duration of  both sensory and motor blockade by synergistic 
action with local anaesthetics. 
Side effects: 
 Arterial hypotension- due to direct inhibition of sympathetic outflow 
from  pre ganglionic neurons in the spinal cord, 
 reduction  in heart rate . 
KETAMINE: 
It blocks the calcium channel on the NMDA ( N- methyl D aspartate ) receptor 
complex and decreases depolarisation by inhibiting excitatory transmission. 
NEOSTIGMINE:                                                                                              
The cholinergic system modulates pain perception by a spinal mechanism. 
Analgesia by neostigmine is associated with high incidence of nausea and 
vomiting.  
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                       3.  PHYSIOLOGY OF PAIN 
PAIN: 
International association for study of pain has defined pain as an 
unpleasant sensory and emotional experience associated with actual or potential 
tissue damage or defined in terms of such damage. 
There are two components of pain. Neurophysiologically mediated 
sensory component and an emotional component. 
There are two types of pain 
1. Physiological pain is a transient sensation due to noxious mechanical, 
thermal, chemical stimulus each with a clearly defined threshold and without 
causing damage to the nervous system. 
2. Pathological pain is an inflammatory response to tissue injury or damage to 
central nervous system with an alteration in perception. Pain following 
surgery is pathological. 
There are two major theories of pain. 
1. Specificity theory proposed by Von Frey states that pain is due to stimulation 
of specific end organs. 
2. Intensive / Summation / Pattern theory proposed by Gold Scheider states that 
there are no specific pain receptors and any sensory stimulus if sufficiently 
severe would produce pain. 
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ORGANISATION OF PAIN PATHWAYS: 
         According to the recent theory, pain pathway is organized as follows 
RECEPTORS: 
Nociceptive receptors are fine, profusely branched, free nerve endings 
covered by Schwann cells with little or no myelin. They are present in skin, 
viscera and other organs. 
There are three types of receptors 
1. Mechanosensitive nociceptors activated by mechanical stimuli. 
2. Mechanothermal nociceptors activated by mechanical and thermal stimuli 
>43ºC. 
3. Polymodal pain receptors respond to mechanical, thermal and chemical  
stimuli like hydrogen, potassium ions, histamine, serotonin, prostaglandins.            
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 FIRST ORDER NEURONS: 
Mechanosensitive and mechanothermal pain receptors transmit impulses 
through thinly myelinated A δ fibres of 1-5 µ diameter with conduction velocity 
of 15-30 metres per second. This is responsible for fast pain which is sharply 
localized. Polymodal pain receptors transmit impulses through unmyelinated C 
fibres of 0.4-1.1 µ diameter with conduction velocity of 0.5 – 2 meters per 
second. This is responsible for the poorly localized slow pain. Transmission 
through both these fibres causes the “ Double response of Lewis”. The 
peripheral afferent fibres have their cell body in the dorsal root ganglion and 
project via the lateral part of the dorsal root called “ Tract of Lissauer”. They 
terminate in dorsal horn of spinal cord within 1 to 2 segments of entry.  A δ 
fibres terminate in lamina 1 (marginal cell layer of Waldeyer) and lamina 5 
(wide dynamic range of neurons which respond to other modalities also). 
Unmyelinated C fibres terminate in lamina 2 and 3 (substantia gelatinosa). 
 
SECOND ORDER NEURONS: 
They arise from the cell and connect with ventral and lateral horn cells in 
the same and adjacent spinal segments which subserve both somatic and 
autonomic reflexes. Around 75% of other sensory neurons project contralaterally 
after decussating in the anterior commissure  1-3 segments higher than the root 
of entry and divide into two ascending tracts.  
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Neospinothalamic / Lateral spinothalamic tract:  
It ascends in the anterolateral funiculus of spinal cord to brain stem and 
thalamus. It contains fast conducting fibres which transmit specific localised 
pain, identifiable in quality and intensity causing “First Pain “. The fibres are 
arranged in such a way that fibres from lower part of the body are superficial and 
from upper part of the body are innermost. 
Palaeospinothalamic / Ventral spinothalamic / Spinoreticulothalamic tract: 
It is medially placed and contains slowly conducting fibres responsible 
for “Second Pain” and has connections with  brainstem, limbic and subcortical 
regions. 
Thalamic terminus: 
          Most of the fibres of spinothalamic tract terminate in the nucleus ventro 
posterolateralis which is the major sensory relay nucleus. The other fibres 
terminate in the posterior group of nuclei, ventrobasal complex and hypothalamic 
nuclei. 
THIRD ORDER NEURONS / THALAMOCORTICAL PROJECTIONS: 
Posterior thalamic nuclei project to the post central cortex and upper bank 
of sylvian fissure and subserve tactile and proprioceptive stimuli with 
discriminative sensory function. Pain afferents received from mesencephalic 
offset of anterolateral funiculus project to the amygdaloid nuclei and other areas 
related to affect the emotion. 
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 PERCEPTION OF PAIN :  
The threshold for the perception of pain is the lowest intensity of stimulus 
recognized as pain. The conscious awareness or perception of pain occurs at the 
thalamic level and thalamic pain occurs when the thalamocortical pathway is 
destroyed. Somatosensory cortex is essential for the accurate localization, 
appreciation of intensity and other discriminative aspects of pain. Prefrontal 
cortex subserves the unpleasant affective and emotional reaction to pain. 
 
GATE CONTROL THEORY OF PAIN:  
It was propounded by Melzack and Walls in 1965. It states that 
modulation of pain impulses in the dorsal horn can control further synaptic 
transmission via the spinothalamic tract. It states that stimulation of large afferent 
fibres excite the I cells (inhibitory cells) in the lamina 2 and 3 of dorsal horn 
which in turn cause pre and post synaptic inhibition of secondary transmission 
neurons (T cells) in lamina 5 of dorsal horn and interrupt pain pathway. 
Conversely stimulation of small pain afferents (C fibres) inhibit the I cells 
leaving the T cells in the excitatory state thus facilitating transmission of pain. 
 
Endogenous opioids  and spinal modulation of pain perception:  
       Hughes et al described endogenous morphine like substances with analgesic 
activity called endorphins. There are 5 endorphins, 
 Metenkephalin, 
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 Leuenkephalin, 
 Betaendorphin, 
 L endorphin  
 R endorphin. 
Metenkephalin and Leuenkephalin:  
      They are inhibitory neurotransmitters at the primary afferent nociceptive 
site. They act through release of substance P. 
Dynorphins:  
    Control nociception at the spinal cord level through activation of kappa 
receptors. It is present in lamina 1 to 5 of dorsal horn. 
L-endorphin and R- endorphins : 
   Breakdown products of beta endorphins. 
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                     4.    PHARMACOLOGY OF OPIOIDS 
Opium is extracted from the capsule of a poppy plants (Papaver somniferum). It 
is a brown residual material and has two active alkaloid ingredients, 
phenanthrene derivatives and benzoisoquinoline derivatives.  Morphine, 
codeine and thebaine are derivatives of the former while papaverine and 
noscapine are derivatives of the latter compound. Morphine is naturally 
available at 10% concentration in wild poppy.  
Classification of opioids: 
Natural opioids: Morpine, Codeine 
Semisythetic opioids: Diacetylemorphine and Pholcodine 
Synthetic opioids: Pethidine, Fentanyl, Methdadone, Tramadol 
 LOCATION OF OPIOID RECEPTORS: 
Opioid receptors are located in the areas of brain ( periaqueductal gray matter of 
brainstem, amygdale, corpus striatum, hypothalamus ) and spinal cord ( 
substantia gelatinosa ) that are involved in pain perception, integration of pain 
impulses and responses to pain.  
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                                         Opioid            receptors 
µ1 µ2 κ δ 
Analgesia 
 
Analgesia(spinal)  Analgesia 
 
Analgesia  
 
Euphoria  Depression of 
ventilation 
Dysphoria  Depression of ventilation 
Miosis  Constipation  Miosis  Constipation  
 
Table 4 shows actions of opioid receptor 
 
 Mu  (µ) Delta (δ) Kappa (κ) 
Fentanyl +++ +++ +++ 
Morphine +++  + 
Sufentanil +++ + + 
Nalbuphine   ++ 
Butarphanol   +++ 
 
Table  5. shows  effects of opioids on  receptor affinity 
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Drug  analgesia Respiratory 
depression 
Antitussive 
effect 
constipation Dependence 
liability 
                          Mixed     Opioid  Agonist   antagonist  
Pentazocine +++ ++ 0 + + 
Butarphanol +++ ++ 0 + + 
Nalbuphine +++ ++ 0 + + 
Buprenorphine +++ ++ + ++ + 
 
NALOXONE: 
Pure opioid receptor antagonist. Recommended dose is 0.4 – 0.8 mg. 
When carefully titrated and administered it often restore spontaneous ventilation 
without reversal of adequate analgesia. Onset of action is 1 – 2 minutes with 
half life of 30 – 60 minutes. 
NALTREXONE: 
Pure opioid antagonist, long acting than naloxone. Duration of action is 
30 – 90 minutes. Effective  oral prophylactic against pruritus and vomiting 
associated with intrathecal morphine. 
General Pharmacological Actions of opioids: 
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Analgesia: 
        Morpine is the most efficacious analgesic. The analgesia is dose 
dependent. Dull visceral pain is better relieved than sharp somatic pain. The 
degree of analgesia is dose dependent. At high doses it can relieve even very 
sharp somatic pain and to a very high degree. It is most effective at relieving 
nociceptive pain arising from stimulation of nerve endings compared to 
neuropathic pain. 
         Intrathecal injection has been shown to cause segmental analgesia without 
affecting other modalities of sensation, while in the spinal cord it acts directly 
on the substansia gelatinosa to inhibit release of excitatory neurotransmitters 
from the afferent fibres.  
Sedation: 
        Indifference to self and surroundings accompanied by drowsiness occurs. 
This differs from hypnotics in that there is no motor incoordination involved. 
With increase in dose, sleep and coma can occur.  
Respiratory center: 
       The respiratory center gets depressed and both rate and tidal volume are 
affected. Multiple instances of death due to overdose have been recorded. In 
addition to depression of the respiratory center, there is indifference to breathing 
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by the apneic patients themselves. They may not breath unless commanded to 
do so. 
Mood and other subjective effects: 
Opioids have a calming effect on the general population. There is loss of  
apprehension and a feeling of detachment. There is a lack of initiative and 
mental clouding. All of these are perceived as unpleasant sensations in the 
absence of pain. The feeling of detachment is described as “floating” by addicts.  
Cough center: 
     The cough center is affected more than the respiratory center. Cough reflex 
is suppressed severely even at low doses. This is being used in cough 
suppressants like codeine.  
Cardio-vascular system: 
         Morphine causes differential vasodilation which is greater in the systemic 
circuits compared to the pulmonary circuits resulting in a shift of blood to the 
systemic circulation. The vasodilation is mediated by multiple mechanisms 
including release of histamine, a direct depressant action on the vasomotor 
center and a direct action on the tone of the vessels.  This results in overall 
reduced cardiac output due to the decreased peripheral resistance. 
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Neuroendocrine system: 
       Hypothalamic afferent collaterals are suppressed. There is universal 
suppression of all neuro-endocrine secretion. The posterior pituitary is affected 
more than the anterior pituitary. But these effects are short-lived and tolerance 
develops to these effects immediately.
(7)
 
GIT: 
        Constipation is a major result of the action of morphine. There is increased 
tone and segmentation movements but decreased propulsive movements. Spasm 
of pyloric, ileocaecal and anal sphincters can occur. There is also central action 
causing inattention to defecation reflex. 
Other smooth muscles: 
       Morphine causes spasm of the sphincter of Oddi. This can result in 
increased biliary pressure and biliary colic. The tone of both detrusor and the 
sphincter is increased resulting in difficulty in micturition and a feeling of 
urgency. It may slightly prolong labor and cause significant broncho 
constriction in asthmatics due to the release of histamine. 
Pharmacokinetics: 
        A high and variable first-pass metabolism results in poor oral absorption of 
morphine with only about 20-25% bioavailability. There is a very high amount 
of distribution in the tissues compared to the plasma resulting in a high volume 
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of distribution. The half-life of the drug ranges from 4-6 hours because of the 
extensive tissue distribution. 
Adverse Effects: 
      Dysphoric effects like sedation, lethargy and clouding of cognition can 
occur. Vomiting, constipation and respiratory depression are common even at 
low therapeutic doses. Blurring of vision and urinary retention can occur in the 
elderly. Hypotension can occur in mobile patients. Allergic reactions have been 
reported but are few and far between. Local reactions at the sites of injections 
are more common . 
Dependence and Tolerance: 
Morphine exhibits a high degree of tolerance.Tolerance occurs for all 
actions except constipation and miosis.Subjects tolerant to morphine exhibit 
tolerance to most CNS depressants as well. Withdrawal leads to drug seeking 
behavior in patients. Physical manifestations seen are mostly the opposite of the 
effects – lacrimation, sweating, diarrhea, mydriasis, hyperventilation, 
vasoconstriction and if prolonged weight loss and suicidal tendencies. 
Interactions: 
Tricyclic anti-depressants, Mono-amine oxidase, phenothiazine, 
amphetamines and  neostigmine potentiate the effect of morphine. Morphine in 
turn retards the digestion of drugs by delaying gastic emptying. 
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PHARMACOLOGY OF FENTANYL         
 
                            Structural formula of fentanyl 
   Synthetic opioid related to the phenylpiperidines. The actions of fentanyl is 
similar to those of µ-receptor agonists.  
 
PHARMACOLOGICAL PROPERTIES 
100 times more potent than morphine, most commonly administered 
intravenously, can be administered through epidural, intrathecal, transdermal 
and, oral route. The plasma concentration of fentanyl  required for postoperative 
analgesia was approximately 1.5 ng / ml
(8)
 
The advantage of liphophiicity is that the risk of delayed respiratory 
depression is less when compared with morphine . The time to peak analgesic 
effect after intravenous administration is  5 minutes. Fentanyl has high degree 
of cardiac stability due to less effect on heart rate and blood pressure, minimal 
myocardial depression with no release of histamine. High doses of fentanyl or 
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sufentanil are commonly used as the primary anesthetic for patients undergoing 
cardiovascular surgery.  
 
Fentanyl Dose  
As Analgesic  2 – 6 µg / kg 
As infusion 0.5 – 5 µg / kg / hr 
For induction 4 – 20 µg / kg 
 
   Table 7 showing various dosage of fentanyl 
 
PHYSIOCHEMICAL PROFILE: 
 
Molecular weight    528.29 
pKa    8.4 
% unionized at pH 7.4    8.5% 
% bound to plasma proteins    84% 
Potency      100 > than morphine 
 
Table 8 showing physiochemical properties of fentanyl 
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PHARMACOKINETIC PROFILE: 
Volume of distribution at steady state      335 litres 
Clearance       1530 ml / minutes 
Effect site equilibration time      6.8 minutes 
Hepatic extraction ratio      0.8 – 0.1 
Context sensitive half time      260 minutes 
Elimination half time      3.1 – 6.6 hours 
First pass pulmonary uptake      75% 
 
Table 9 showing pharmacokinetics of fentanyl 
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                   PHARMACOLOGY OF  STEROIDS 
 
Two classes of steroids:  
The corticosteroids, and androgens.  
           The corticosteroids are classified as glucocorticoid (carbohydrate 
metabolism–regulating) and mineralocorticoid (electrolyte balance–regulating). 
The important glucocorticoid and mineralocorticoid in human is cortisol and 
aldosterone respectively. 
GENERAL MECHANISMS FOR CORTICOSTEROID EFFECTS: 
   Interaction  with specific receptor proteins in target tissues  upregulate 
the expression of corticosteroid-responsive genes, which changes  the levels and 
array of proteins synthesized by the various target tissues. 
 MOLECULAR MECHANISM OF ANTI INFLAMMATORY EFFECTS 
OF GLUCOCORTICOIDS: 
Glucocorticosteroids are potent anti-inflammatory agents. This anti-
inflammatory effect may be produced via a variety of mechanisms. A group of 
structurally related, calcium-dependent phospholipid-binding proteins, 
annexins, which were formerly known as lipocortins or calpactins, had been 
shown to be inducible by glucocorticoids. Annexin I has been reported to inhibit 
sPLA2 activity in vitro. These observations led to the hypothesis that the 
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inhibition of sPLA2 by annexins is the mechanism of the anti-inflammatory 
action of glucocorticoids.
(9)
 
The prolongation of analgesic duration  of perineural administration of 
dexamethasone may be  secondary to local action on nociceptive- C fibres 
mediated via glucocorticoid receptors and upregulation of function of potassium 
channels in excitable cells 
CARBOHYDRATE AND PROTEIN METABOLISM : 
  Stimulation of  glucose  synthesis from amino acids and glycerol and 
storage as glycogen in liver. There is diminished glucose utilisation with 
increased protein breakdown in the periphery resulting in increased blood 
glucose. Glycemic control can be worsen in patients taking corticosteroids. 
LIPID METABOLISM: 
 Redistribution of body fat results in   increased fat accumulation in  
supraclavicular area, nape of the neck, face along  with a loss of fat in the 
extremities. An increase in free fatty acid level occurs due to augmentation of 
lipolytic effects of growth hormone and adrenergic agonists. 
ELECTROLYTE AND WATER BALANCE : 
 In patients with glucocorticoid deficiency there is increased secretion of 
vasopressin, which stimulates water reabsorption in the kidney. Steroids 
interfere with Ca
2+
 uptake in the gut and increase Ca
2+
 excretion by the kidney 
leading to decreased total body Ca
2+
 stores. The most striking cardiovascular 
effects of corticosteroids result from mineralocorticoid-induced changes in renal 
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Na+ excretion, leading to increased sodium and water retention  in primary 
aldosteronism there is enhanced response to  vasoactive drugs. 
SKELETAL MUSCLE: 
  In  Addison‟s disease, weakness , fatigue and diminished work capacity 
are the prominent symptoms. In primary aldosteronism weakness and fatigue 
occurs due to steroid myopathy. 
CENTRAL NERVOUS SYSTEM: 
Patients with adrenal insufficiency exhibit apathy, depression and 
irritability. Replacement therapy will alleviate such symptoms. Treatment with 
glucocorticoids may result in behavioural changes such as mania, insomnia and 
restlessness and these abnormalities disappear with cessation of therapy. 
BLOOD AND FORMED ELEMENTS: 
Corticosteroids exert minimal effects on erythrocytes and haemoglobin as 
evident by polycythemia in cushing syndrome, an normocytic normochromic 
anaemia in addisons disease. A single dose of hydrocortisone can decrease the 
circulating levels of these cells within 4-6 hours . This persists for 24 hours and 
it results from redistribution of cells away from periphery. 
 
 
 
 
 
45 
 
PHARMACOLOGY OF DEXAMETHASONE: 
              
                       
          Structural formula of dexamethasone  
PHARMCOKINETICS OF DEXAMETHASONE 
Bioavailability      80 – 90 % 
Protein binding      70 % 
Metabolism       hepatic 
Half life      36 – 54 hours 
Excretion        renal 
Molecular weight       392.4 g / mol 
 
Table 10 showing pharmacokinetics of dexamethasone 
       Dexamethasone is a high potency, long acting glucocorticoid with little 
mineralocorticoid effect. It has been used intravenously for prophylaxis of 
postoperative nausea. Single doses of epidural  dexamethasone and other 
glucocorticoids have been reported to improve analgesia after various surgeries. 
        Acute noxious stimulation of peripheral tissues leads to sensitization of 
dorsal horn neurons of the spinal cord by the release of excitatory amino acids 
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such as glutamate and aspartate. These amino acids activate N-methyl-D-
aspartate receptors resulting in calcium ion influx. As a result, increased 
intracellular calcium activates phospholipase A2 which converts membrane 
phospholipids to arachidonic acid. Simultaneously, there is up-regulation of the 
expression of cyclo-oxygenase 2 in the spinal cord, leading to prostaglandin 
E2 synthesis, which results in a hyperalgesia.  
MECHANISM OF ACTION OF EPIDURAL STEROIDS: 
     Dexamethasone and other steroids act by suppression of transmission in thin 
unmyelinated C fibres while not affecting myelinated Aβ  fibres. It exerts these 
action through direct membrane stabilising effect and indirectly through 
mediators.These direct and indirect actions lead to decrease in intraneuronal 
edema and venous congestion thereby reducing ischemia and improving pain. 
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5. PHARMACOLOGY  OF  BUPIVACAINE 
                              
                                Structural formula of bupivacaine 
       It is an amide local anaesthetic first synthesized in Sweden by Ekenstam 
and his colleagues in 1957 and used clinically L.J.Telivuo in 1963. Its 
molecular weight is 288. ( 1-butyl- N-( 2,6, dimethyl phenyl piperidine-2-
carboxamide) 
Prepared as a clear solution of 0.25%, 0.5% solution of bupivacaine 
hydrochloride. The hyperbaric solution used for subarachnoid block contains 80 
mg / ml of glucose.  
PHARMACOKINETICS: 
      At pH 7.4 only 15% exist in non ionised form. Absorption depends on the 
site of injection, dosage and use of epinephrine. 
pKa     8.1 
Protein binding     95 % 
Lipid solubility     28 % 
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Volume of distribution      73 litre 
Clearance of drug from plasma      0.471 litre / minute 
Elimination half life      210 minute 
Onset time      5 – 7 minute 
                Table 11 showing pharmacokinetics of  bupivacaine 
 
MECHANISM OF ACTION: 
Local anesthetics such as bupivacaine block the generation and 
conduction of nerve impulses, presumably by increasing the threshold for 
electrical excitation in the nerve, by slowing the prolongation of the nerve 
impulse and reducing the rate of rise of the action potential. The progression of 
anesthesia is related to the diameter, myelination and conduction velocity of 
affected nerve fibres. The analgesic effects are thought to be due to its binding 
to the prostaglandin E2 receptors. 
METABOLISM: 
The possible pathway for metabolism of bupivacaine include aromatic 
hydroxylation, N-dealkylation, amide hydrolysis and conjugation. Only the N-
dealkylated metabolite N-desbutyl bupivacaine has been measured in the blood 
or urine.5 % of the dose is excreted in the urine as pipcolloxylidine.16 % is 
excreted unchanged.  
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ROUTES OF ADMINISTRATION: 
May be administered  by infiltration, intrathecally or epidurally and for 
peripheral nerve blocks. The total  dose of bupivacaine should not exceed 2 – 3 
mg / kg ( with or without epinephrine ). 
SYSTEMIC TOXICITY: 
CARDIOVASCULAR SYSTEM: 
      Bupivacaine is markedly cardiotoxic. It binds to specific myocardial 
proteins. In toxic concentrations the drug decreases the peripheral vascular 
resistance and myocardial contractility producing hypotension and 
cardiovascular collapse. Cardiotoxic plasma concentration is 8 – 10 µg / ml.  
     20 % intra lipid can be given for bupivacaine toxicity. The dose is 1.5 ml / 
kg as initial bolus can be repeated 1 to 2 times for persistent asystole. Infusion 
can be started at dose of 0.25 ml / kg / min for 30 – 60 min.  
CENTRAL NERVOUS SYSTEM: 
       During accidental overdosage or direct vascular injections the clinical signs 
are numbness of tongue, light headedness, visual and auditory disturbances, 
muscle twitching, tremors. The signs may progress to generalised convulsions 
of the tonic clonic nature. The typical plasma concentrations of bupivacainne 
associated with seizures is 4.5 – 5.5 µg / ml. 
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     6.  METHODS OF POST OPERATIVE ANALGESIA 
SYSTEMIC OPIOIDS: 
Parenteral opioid analgesics are one of the cornerstone options for the 
treatment of postoperative pain. These agents generally exert their analgesic 
effects through μ-receptors in the CNS. Opioids may be administered by the 
subcutaneous, transdermal, transmucosal, or intramuscular route, but the most 
common routes of postoperative systemic opioid analgesic administration are 
oral and intravenous. Opioids may also be administered at specific anatomic 
sites such as the intrathecal or epidural space . 
INTRAVENOUS PATIENT CONTROLLED ANALGESIA: 
  Intravenous patient-controlled analgesia (PCA) optimizes delivery of 
analgesic opioids and minimizes the effects of pharmacokinetic and 
pharmacodynamic variability in individual patients. Although some equipment 
related malfunctions have been reported, the PCA device itself is relatively free 
of problems. Most of the problems related to PCA use result from user or 
operator error.  
The lockout interval may also affect the analgesic efficacy of intravenous PCA. 
In essence, the lockout interval is a safety feature of intravenous PCA,  and 
most intervals range from 5 to 10 minutes. 
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NON STEROIDAL ANTI INFLAMMATORY AGENTS: 
 NSAIDs generally provide effective analgesia for mild to moderate pain. 
NSAIDs are also traditionally considered a useful adjunct to opioids for the 
treatment of moderate to severe pain. NSAIDs may be administered orally or 
parenterally, rectally  and are particularly useful as components of a multimodal 
analgesic regimen by producing analgesia through a different mechanism from 
that of opioids or local anesthetics. Few NSAIDS that are commonly used 
includes Diclofenac ( 50 – 75  mg IM ), Ketorolac ( 30 mg IM ), paracetamol IV 
15 – 20 mg / kg. 
KETAMINE HYDROCHLORIDE: 
Perioperative subanesthetic doses of ketamine reduce rescue analgesic 
requirements or pain intensity. It reduces 24-hour PCA morphine consumption 
and postoperative nausea or vomiting and had minimal adverse effects. 
Ketamine has also been administered epidurally and intrathecally,
 
but racemic 
mixtures of ketamine have been found to be neurotoxic and therefore the use of 
neuraxial ketamine is discouraged.  
REGIONAL ANALGESIA TECHNIQUES: 
The analgesia provided by epidural and peripheral techniques is superior to that 
with systemic opioids and use of these techniques may even reduce morbidity 
and mortality. It includes 
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 Local anesthetic infiltration 
 Nerve blocks 
 Peripheral or plexus block 
 Epidural – single shot, continous infusion, patient controlled epidural 
anesthesia 
 Intrathecal – single shot, continous infusion. 
 DOSING OF COMMON NEURAXIAL OPIOIDS: 
DRUG Intrathecal single 
dose 
Epidural single 
dose 
Epidural infusion 
Fentanyl 5-25 µg 50-100 µg 25-100 µg/hr 
Sufentanil 2-10 µg 10-50 µg 10-20 µg/hr 
 Morphine  0.1-0.3 mg 1-5 mg 0.1-1 mg/hr 
Pethidine 10-30 mg 20-60 mg 10-60 mg/hr 
 Table 12 showing dosage of common neuraxial opioid 
Administration of a single dose of opioid may be efficacious as a sole or 
adjuvant analgesic agent when administered intrathecally or epidurally. The site 
of analgesic action for hydrophilic opioids is spinal. A single bolus of epidural 
fentanyl may be administered to provide rapid postoperative analgesia, however 
diluting the epidural dose of fentanyl (typically 50 to 100 µg) in at least 10 mL 
of normal saline is suggested to decrease the onset and prolong the duration of 
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analgesia, possibly as a result of an increase in initial spread and diffusion of the 
lipophilic opioid
(11) 
Single-dose epidural morphine is effective for postoperative 
analgesia and may decrease postoperative patient morbidity in selected patients 
but is associated with following adverse effects. 
 ADVERSE EFFECTS: 
 Hypotension  
 Nausea and vomiting 
 Pruritus 
 Respiratory depression 
 Urinary retention 
 Mental state changes 
 Central nervous system excitation 
 Herpes labialis reactivation 
 Gastrointestinal dysfunction. 
CONTINUOUS EPIDURAL ANESTHESIA & ANALGESIA: 
  Analgesia delivered through an indwelling epidural catheter is a safe and 
effective method for management of acute postoperative pain. Postoperative 
epidural analgesia can provide analgesia superior to that with systemic opioids 
Insertion of the epidural catheter congruent to the incisional dermatome  results 
in optimal postoperative epidural analgesia by infusing analgesic agents to the 
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appropriate incisional dermatomes, providing superior analgesia, minimizing 
side effects (e.g., lower extremity motor block and urinary retention), and 
decreasing morbidity. Combination of opioid with local anaesthetic ,opioid,or 
local anaesthetic alone can be used for infusion.  
PATIENT CONTROLLED EPIDURAL ANALGESIA (PCEA) 
.  PCEA allows individualization of postoperative analgesic requirements and 
may have several advantages over continous epidural infusion, including lower 
drug use and greater patient satisfaction 
Analgesic solution 
Continous rate 
ml/hr 
Demand dose 
ml 
Lockout 
interval 
ml/min 
0.05%Bupivacaine+4µg/ml Fentanyl 4 2 10 
0.0625%Bupivacaine+5µg/ml Fentanyl 4-6 3-4 10-15 
0.1%Bupivacaine+5µg/ml    Fentanyl 6 2 10-15 
0.2%Ropivacaine+5µg/ml Fentanyl 5 2 20 
Table 13  Patient controlled epidural analgesia regimens. 
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THORACIC PARAVERTEBRAL BLOCK: 
  Used for thoracic, breast,  upper abdominal surgery and for the treatment of rib 
fracture pain.probable site of action include somatic and sympathetic nerve with 
epidural blockade. Can be administered as single injection or as continous 
infusion. 
INTERPLEURAL ANALGESIA: 
Inferior to epidural and paravertebral analgesia for control of postoperative 
pain, preservation of lung function after thoracotomy. 
INTRA ARTICULAR ANALGESIA: 
 Local peripheral administration of opioids (e.g intra-articular injection 
after knee surgery) may provide analgesia for up to 24 hours after surgery
 
and 
decrease the incidence of chronic pain. Peripheral opioid receptors are found on 
the peripheral terminals of primary afferent nerves and are upregulated during 
inflammation of peripheral tissues. 
OTHER TECHNIQUES: 
TENS(transcutaneous electrical nerve stimulation), acupuncture and 
psychological approaches. 
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                            7.  REVIEW OF LITERATURE 
1. Youn yi jo et al(13) compared outcomes of epidural ropivacaine 0.25% and 
epidural ropivacaine 0.25% with dexamethasone 5 mg in patients 
undergoing radical subtotal gastrectomy.He compared VAS scores and 
rescue analgesic requirements among these group of patients and 
concluded that VAS scores and rescue analgesic requirements were less 
in dexamethasone treated group. 
2. Farshad M Ahadian et al(14) in his study compared the efficacy of three 
different doses( 4 mg, 8 mg, 12mg) of transforaminal epidural 
dexamethasone in relieving radicular pain.He measured the outcomes in 
terms of VAS scores and subject satisfaction scale.It showed that 
improvement in radicular pain with no difference in efficacy of different 
doses of dexamethasone. 
3. Wang et al(15) compared the effect of epidural dexamethasone in relieving 
post epidural backache in patients undergoing hemorrhoidectomy. In the 
study group I patients received 25 cc of 2% lignocaine with 1 cc normal 
saline. Group II patients received 25 cc of 2% lignocaine with 5 mg 
dexamethasone. He found decreased  severity of backache in group II 
patients. 
4. Thomas et al (16) evaluated the efficacy of epidural dexamethasone in 
reducing post operative analgesic requirements following laprascopic 
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cholecystetcomy. In that study group I patients received IV 
dexamethasone 5 mg and 8 cc of 0.25% bupivacaine epidurally. Group II 
patients received IV normal saline 2 cc with 8 cc of 0.25% bupivacaine 
and dexamethasone epidurally. He concluded in the study that group II 
patients receiving  epidural dexamethasone 5 mg had effective post 
operative pain relief and less systemic opioid requirements following 
laprascopic cholecystectomy. 
5. Jehan et al (17) studied the effect of  preoperative epidural dexamethasone 
and magnesium sulphate in patients undergoing abdominal surgeries. In 
the study, group I patients received 12cc of 0.5% bupivacaine with 
morphine 2 mg and magnesium sulphate 50mg epidurally. Group II 
patients received 12 cc of 0.5%bupivacaine with morphine 2 mg and 
dexamethasone 6 mg epidurally. He concluded that with co 
administration of magnesium sulphate 50 mg or dexamethasone 6 mg as a 
single dose in preoperative period was associated with less postoperative 
narcotic consumption and VAS scores. 
6. W.Neill et al (18) studied the effects of epidural methyl prednisolone 40 
mg and morphine 5mg along with control group having normal saline in 
patients undergoing surgery for spinal stenosis. He found that the 
postoperative analgesic requirement  was less in group of patients 
receiving epidural morphine or methylprednisolone or combination of 
both. 
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7. Atsuhiro Kikuchi et al19) studied the effect of intrathecal and epidural 
methyl prednisolone in relieving the  severity of pain due to post herpetic 
neuralgia. Group I patients received 40 mg of methylprednisolone 
epidurally and group II patients received 40 mg of methylprednisolone 
intrathecally. He concluded that pain severity was less in patients 
receiving intrathecal  methylprednisolone due to decreased inflammatory 
reaction in CSF. 
8. Saeid Abrishamkar et al(20) studied the effect of epidural 
methylprednisolone 40 mg and local anesthetic ( 1 cc of 0.5% 
bupivacaine ) impregnated in adipose tissue in relieving low back pain 
and radicular pain in lumbar disc surgery. He found that combination of 
methylprednisolone and local anaesthetic increased the duration of pain 
free interval. 
9. Park CH(21) compared  the effects of transforaminal injection of 
dexamethasone 7.5 mg and triamcinolone 40 mg in patients with lumbar 
disc herniation  and found that triamcinolone is more effective in 
relieving lumbar radiculopathy than dexamethasone. 
10.  Hudan et al(22)  compared the pain relief in patients with lumbar canal 
stenosis by epidural administration of methylprednisolone 80 mg along 
with 0.125% bupivacaine  and  triamcinolone 80 mg with 0.125% 
bupivacaine epidurally. He found better pain relief in patients receiving 
epidural methylprednisolone. 
59 
 
11. Khafagy et al(23) studied the effect of epidural dexamethasone in patients 
undergoing lower abdominal surgeries. In that study group I patients 
received epidural 10cc of 0.25% bupivacaine and fentanyl 50µg 
epidurally and group II patients received 10cc of 0.25 bupivacaine with 
dexamethasone 4 mg. He found that addition of epidural dexamethasone 
improved postoperative pain relief and decreased analgesic requirement. 
12. Guilfoyle MR(24)  studied the effect of epidural fentanyl in patients 
undergoing surgery for lumbar canal stenosis. In the study group I 
patients received normal saline epidurally at the end of surgery and group 
II patients received epidural fentanyl 100 µg . Postoperative pain relief 
was compared with VAS scores which showed effective post operative 
analgesia in group of patients receiving bolus epidural fentanyl.     
13. Ganesh A et al(25) studied the effects of epidural fentanyl infusion for post 
operative analgesia in infants undergoing thoracotomy . One group of 
patients received epidural infusion of 0.1 % bupivacaine and other group 
received epidural infusion of 0.1% bupivacaine with fentanyl 2µg / ml . 
He concluded that there was improved analgesia in group receiving 
fentanyl infusion with better pain scores and less rescue analgesic 
requirements with nalbuphine. 
14. Szabova A et al(26) - postoperative epidural butorphanol / bupivacaine 
with the epidural analgesic infusion fentanyl / bupivacaine in children. 
Epidural fentanyl provided similar analgesia to epidural butarphanol 
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after urological procedures in children, but butorphanol caused less 
pruritus than fentanyl. Epidural analgesia with butorphanol / 
bupivacaine is effective than epidural fentanyl / bupivacaine in 
children undergoing urological procedures.  
15. Marcelo Soares Privado(27) compared the effect of epidural versus 
intravenous fentanyl in patients undergoing orthopaedic procedure. Group 
I patients received 100µg fentanyl epidurally and group II patients 
received 100µg fentanyl intravenously. The study outcome was less need 
of supplementary analgesia with tenoxicam in group I patients receiving 
epidural fentanyl. 
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                               8. AIM OF THE STUDY 
To compare the efficacy of epidural dexamethasone versus fentanyl on post 
operative analgesia  
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                                 9. MATERIALS AND METHOD 
After getting Ethical committee approval from Goverment Kilpauk Medical 
College Hospital. Chennai 10, we conducted the study in our hospital in 60 
adult male patients aged between 25 – 45 years belonging to ASA Physical 
status I and II undergoing  elective hernioplasty under epidural anesthesia after 
obtaining written informed consent. 
STUDY DESIGN: 
Double blinded randomized prospective study. 
 Patients were randomly allocated into one of the three groups (20 patients 
per group) by lotting method.  
METHOD OF BLINDING: 
          Patients and the person performing the epidural technique was unaware 
of the epidural drug composition. The drug solution was prepared by an 
anaesthesiologist assistant in the operating room and was labelled 
accordingly. 
PATIENT SELECTION: 
       All the 60 patients were evaluated clinically, biochemically and assessed 
for hernioplasty under epidural anesthesia considering the inclusion and 
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exclusion criteria. Then the patients were randomised into three groups. 
STUDY PERIOD: 
From onset of epidural blockade to onset of postoperative pain with VAS > 5. 
OBSERVATION PERIOD: 
For 24 hours postoperatively. 
INCLUSION CRITERIA: 
 Adult male patients aged 25 – 45 years 
 ASA physical status I & II 
 For uncomplicated inguinal hernia surgery 
EXCLUSION CRITERIA : 
 Patient unwilling for the procedure 
 Obese 
 Hypertension 
 Diabetes mellitus 
 History of peptic ulcer disease 
 Those received corticosteroids or immune suppressive drugs in the last 6 
months 
 Those with contraindications to steroids 
 Patients on anticoagulants 
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 Patchy or inadequate blockade which required supplemental narcotics or 
general anesthesia. 
PATIENT GROUPS: 
60 patients enrolled in the study were randomly allocated into three groups. 
 Group 1: Patients receiving 11 cc of  0.5 % bupivacaine  plus normal 
saline 1 cc epidurally. 
 Group 2: Patients receiving 11 cc of 0.5 % bupivacaine  plus 50 µg 
fentanyl epidurally. 
 Group 3: Patients receiving 11 cc of 0.5 % bupivacaine plus 4 mg 
preservative free dexamethasone  epidurally. 
All patients received a total volume of 15 ml of study drug including 3 ml of 
test dose plus 1 ml of adjuvant. The level of blockade was then noted.  
MATERIALS USED: 
 16 Gauge Tuohy needle 
 18 Gauge epidural catheter 
 Loss of resistance syringe 
 10 ml syringe  
 Local anesthetic solution ( 3 ml of 0.5 % bupivacaine with 
epinephrine 1  in 2,00,000 dilution ) for test dose. 
 0.5% bupivacaine  
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 Inj. Fentanyl 
 Inj. Dexamethasone sodium phosphate ( preservative free ) 
 22 g needle for pin prick test 
PARAMETERS TO BE OBSERVED: 
1.Demographic parameters 
2. baseline parameters 
3. onset of anesthesia 
4.Time for two segment regression of sensory and motor blockade. 
5. Duration of analgesia 
6.Incidence of side effects like nausea, vomiting, sedation, 
hypotension 
CONDUCT OF STUDY: 
   In the pre anesthetic visit, study plan was explained in detail to all the 
patients. Written informed consent obtained after explaining the study  in 
their own langage. 
 After getting informed consent, patient was prepared for the surgery with 
fasting period of 8 hours. Antacid prophylaxis was given with inj. Ranitidine 
50 mg IV 2 hours before surgery. Baseline vital  parameters were recorded in 
the patient waiting room. 
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CONDUCT OF EPIDURAL BLOCK: 
 In the operating room patient was connected to five lead ECG, Non 
Invasive Blood Pressure, Pulse Oximeter and baseline parameters were 
recorded. An intravenous line was established with 18 gauge venflon and 
preloaded with 15 ml / kg of ringer lactate. 
      Under strict  aseptic precautions with the patient in right lateral position 
local anaesthtic infiltration was given with 1 % lignocaine. Epidural space was 
identified at L2 – L3 space through 16 gauge Tuohy needle by loss of resistance 
technique. An 18 gauge epidural catheter was inserted in L2 – L3 space and 5 
cm of catheter kept inside epidural space. Test dose was given with 3 ml of 0.5 
% bupivacaine with epinephrine 1:2,00,000 dilution via catheter before it is 
fixed to rule out intravascular or intrathecal placement.  
After confirming the epidural placement of the catheter, 12 ml of blinded 
study solution was given and level of blockade was noted at 5 min interval till 
20 minutes. Oxygen at 4L/min via venturi mask was provided. If there was any 
hypotension ( systolic blood pressure < 80 mm hg or mean arterial pressure < 60 
mm hg)  Inj. Ephedrine 6mg IV was given along with intravenous fluid. If the 
heart rate fell below 50 / minute, Inj. Atropine 0.6 mg IV was given. The 
respiratory rate and type of respiration was also monitored.  
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 After the administration of study medication, the onset of analgesia and 
the level achieved was noted at 5 min interval. Surgery was allowed to proceed 
when the level of blockade was T8. Throughout the intraoperative period vitals 
like heart rate, systolic blood pressure, mean arterial pressure, oxygen saturation 
and respiratory rate were monitored. 
CONCLUSION OF SURGERY: 
             At the end of surgery the level of sensory blockade was assessed and 
then epidural catheter was removed. The patient was shifted to recovery room 
and observed for 2 hour and vitals were recorded and shifted to Post Anesthesia 
Care Unit .  
ASSESSMENT OF PAIN SCORE: 
          In the PACU, pain score was observed at 30 min, 60 min, 90 min, 180  
min, & then every ½ hourly intervals upto 10hrs  on a 10cm Visual analogue 
scale („no pain‟ at 0 cm end and „worst pain ever‟ at 10cm  end) and for 
occurrence of side effects like nausea, vomiting, pruritus, respiratory 
depression, sedation and changes in hemodynamic variables. 
ONSET AND DURATION OF ANALGESIA: 
 The time since injection of drug into epidural space to the time required 
to obtain sensory blockade upto T8 ( loss of pin prick to 22 gauge needle ) was 
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noted as onset of analgesia. The time between the onset of analgesia and return 
to baseline VAS of 5 was noted as the duration of analgesia . 
 RESCUE ANALGESIA IN THE POSTOPERATIVE PERIOD: 
       When the VAS score was more than 5 or when the patients complained of 
pain, Since the study was concluded Inj. Diclofenac 50mg was given 
intramuscularly and epidural catheter was removed. 
The patients were followed for a period of 24 hours  in PACU for any 
occurrence of nausea, vomiting, sedation, pruritus, respiratory depression 
(RR<10/min),   and parameters like duration of analgesia, hemodynamic 
variables etc were noted. 
Statistical analysis was done on collected data. Analysis of variances 
(ANOVA) was used for comparison of mean values between more than two 
groups. Posthoc test was used to find any significance between the individual 
groups. 
VISUAL ANALOGUE SCALE: 
“ Please make a mark on this line that describes how much pain you are having” 
No         0___1___2___3___4___5___6___7___8___9___10    Worst      
pain                                                                                              pain 
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0- No nausea/vomiting 
1- Nausea 
2- Vomiting 
0 - No pruritus 
1 – pruritus 
Bradycardia HR < 50 / min 
0 – No bradycardia 
1 – presence o bradycardia 
Respiratory depression 
RR < 10 / minute 
0 – no respiratory depression 
1 – presence of respiratory 
depression  
Desaturation Spo2 < 95 % 
0 – no desaturation  
1 – presence of desaturation 
Hypotension  
Systolic blood pressure < 80 
mm hg 
Mean arterial pressure < 60 
mm hg  
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  VISUAL ANALOGUE SCALE 
A Visual Analogue Scale (VAS) is a measurement instrument that tries 
to measure a characteristic or attitude that is believed to range across a 
continuum of values and cannot easily be directly measured (example -the 
amount of pain that a patient feels ranges across a continuum from none to an 
extreme amount of pain).From the patient's perspective this spectrum appears 
continuous and their pain does not take discrete jumps, as a categorization of 
none, mild, moderate and severe would suggest. It was to capture this idea of 
an underlying continuum that the VAS was devised.Operationally a VAS is 
usually a horizontal line, 10cm / 100 mm in length. The patient marks on the 
line the point that they feel represents their perception of their current state. 
The VAS score is determined by measuring in centimetres / millimetres from 
the left hand end of the line to the point that the patient marks.  
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                             10.  OBSERVATIONS & RESULTS 
  As per the study methodology the data of 60 male patients aged 25 – 45 years  
belonging to ASA I & II undergoing elective hernioplasty were included in the 
study and were statistically analysed and compared .The demographic data  was 
analysed and it was found to have statistically no significant difference in 
parameters such as age, height, weight, ASA status. 
S.no parameter Group 1 
(NS) 
Group 2 
(FENTANYL) 
Group 3 
(DEXA) 
p value 
1. Age(yr) 31.10 31.95 32.65 0.908 
2 Weight(kg) 61.33 60.05 62.74 0.707 
3. Height(cm) 159.28 160.50 159.72 0.985 
  
Table 14 shows mean values of  demographic parameters between groups 
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                 Chart – 1 Age distribution between three groups  
  
The mean age of group1, group 2 and group 3 were 31.10, 31.95, 32.65 
respectively. There was no statistically significant difference ( p = 0.908 )  
between the mean age of three groups, which shows these three groups were 
similar with respect to age. 
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     Chart – 2 Weight distribution (in  kg ) between three groups 
 
The mean weight of group 1, group 2 and 3 were 61.33, 60.05, 62.74 
respectively. There was no statistically significant difference ( p = 0.707 ) 
between three groups, which shows these groups were similar with respect to 
weight. 
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 Chart – 3 Height distribution ( in cm ) between three groups 
The mean height of group 1, 2, and group 3 were 159.28, 160.50, 159.72 
respectively. There is no statistically significant difference between three groups 
which shows they are comparable with respect to height. 
S.no parameter Group 1 
( NS )min 
Group 2 
(FENT)min 
Group 3 
(DEXA)min 
p value 
1. Onset of 
analgesia 
5.300 5.075 6.525 0.003 
2. Duration  256.05 347.25 373.00 0.000 
 
Table 15 showing onset and duration of analgesia between groups 
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Chart – 4  diagram showing onset of analgesia significantly shorter in group 2 
patients compared with group 1 and group 3. 
On comparing the mean onset of analgesia between three groups, the group 2 
patients receiving fentanyl ( 5.075 minutes ) had shorter onset of time than 
group 1 patients receiving normal saline ( 5.300 minutes ) and group 3  patients 
receiving  dexamethasone ( 6.525 minutes ). 
The mean onset of analgesia among three groups 
Group 2 < Group 1 < Group 3 
Thus there was statistically significant difference in the mean onset of analgesia 
among the three groups. ( p < 0.05 ). 
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Chart – 5  Diagram shows duration of analgesia is significantly prolonged in 
group 3 patients compared with group 1 and group 2 patients. 
 On comparing the mean duration of analgesia among the three groups, group 3 
patients receiving dexamethasone ( 373 minutes ) had prolonged duration of 
analgesia than the group 2 ( 347.25 minutes ) and group 1 patients ( 256.05 
minutes ). 
Order of duration of analgesia  
Group 3 > group 2 > group 1 Thus there was statistically significant difference 
in duration of analgesia between groups. 
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S.no parameter Group 1 
(NS) 
Group 2 
(FENT) 
Group 3 
(DEXA) 
p value 
1. Nausea   3.55%   20% - 0.000 
2. pruritus -   15% - 0.033 
3. sedation -  25% - 0.000 
4. hypotension 10%  15% 20% 0.070 
  
Table 16  shows side effects between three groups 
     The side effects like nausea, pruritus and sedation were noted in fentanyl 
receiving group than other groups. These side effects were statistically 
significant on comparing between groups. ( p < 0.05 ). Hypotension was noted 
in all groups, but the incidence of hypotension is higher in group 3 patients 
receiving  dexamethasone  than group 2 patients  receiving  fentanyl and group 
1 patients receiving normal saline. None of the patients had bradycardia or 
respiratory depression. 
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Chart – 6 diagram  shows significantly higher incidence of nausea in group 2 
patients. 
The incidence of nausea in group 2 patients receiving fentanyl is 20 % and 
group 1 patients receiving normal saline is 3.5 %. There is nil incidence of 
nausea in group 3 patients receiving dexamethasone. This shows statistically 
significant incidence of nausea in fentanyl receiving group. 
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Chart – 7 diagram shows significantly higher incidence of pruritus in group 2 
 
The incidence of pruritus in patients receiving fentanyl is 15 %. The incidence 
of pruritus is nil in patients receiving dexamethasone and normal saline. This 
shows statistically significant incidence of pruritus in fentanyl receiving group. 
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Chart – 8 diagram showing significantly higher incidence of sedation in group 2 
 
The incidence of sedation was 25 % in group 2 patients receiving fentanyl. 
There was nil incidence of sedation in patients receiving dexamethasone and 
normal saline. This shows statistically significant incidence of sedation in 
patients receiving fentanyl . 
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Chart – 9 diagram  shows higher incidence of hypotension in group 3. 
 
 The incidence of hypotension in  patients receiving dexamethasone, fentanyl, 
normal saline was 20 %, 15 %, 10 % respectively. This shows no statistically 
significant difference between three groups. 
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                                     11.    DISCUSSION 
Based on the observations and results obtained in our study involving 20 
patients in each group are discussed in detail by comparing with the available 
evidences in the literature. The analgesic efficacy of epidurally administered 
0.5% bupivacaine + normal saline ( group 1 ), 0.5% bupivacaine + 50 µg 
fentanyl ( group 2 ) and 0.5% bupivacaine + 4 mg  dexamethasone  ( group 3 ) 
was studied. 
All the demographic variables like age, height, weight were comparable 
to each other. There is no statistically significant difference between the 
parameters. The two segment time regression was comparable between all the 
three groups.( table 14 ) 
MEAN ONSET OF ANALGESIA : 
In our study the mean onset of analgesia was earlier in group 2 patients  
receiving  fentanyl (5.07 minutes ) than group 1 patients receiving  normal 
saline  ( 5.30 minutes ) and group 3  dexamethasone group ( 6.52 minutes ). 
This was found to be statistically significant.( p < 0.05 ) ( table 15 ) 
 The onset of analgesia was earlier in the fentanyl group when 
compared to the control group. This study confirmed that onset of action is 
earlier with combination of  opioid and local anaesthetic than local anesthetic 
alone. This finding correlates with the study done by Manpreet Kaur et al 
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who studied the effect of intrathecal bupivacaine alone and intrathecal 
bupivacaine along with opioids like butorphanol and sufentanil. 
The onset of analgesia was earlier in the control group receiving normal 
saline ( 5.3 minutes ) than compared compared with group 3 receiving 
dexamethasone ( 6.52 minutes ). This correlates with study of Youn Yi Joun et 
al who concluded that  epidural administration of dexamethasone 5 mg in 
patients undergoing radical subtotal gastrectomy resulted in less VAS scores 
and rescue analgesic requirements than control  groups. The onset of action of 
epidural dexamethasone is still unclear. 
  MEAN DURATION OF ANALGESIA: 
      The duration of post operative analgesia was prolonged in group 3 patients 
receiving dexamethasone ( mean 373 minutes ) than  in group 2 patients  
receiving fentanyl ( 347 minutes ) followed by  control group receiving normal 
saline( 256 minutes ). 
The results of our study correlate with study done by Khafagy et al. In 
his study he concluded that epidural dexamethasone resulted in low post 
operative pain score and analgesic requirements and prolonged analgesic 
duration. Results of our study also correlate with the study of Thomas & Beevi 
et al who concluded that patients receiving epidural dexamethasone had less 
post operative VAS scores and analgesic consumption. Dexamethasone had 
84 
 
action at spinal cord level in addition to its action on the peripheral tissues after 
systemic absorption from epidural space. 
TWO SEGMENT REGRESSION TIME: 
The two segment regression time in group 1 and 2 was 120 min and 131.5 
minutes respectively. The regression time was 122 min in group 3 patients. This 
was comparable with  the three groups. 
SIDE EFFECTS: 
There was statistically significant difference in the incidence of nausea, 
sedation, and pruritus in group 3 patients receiving dexamethasone compared 
with group 2 patients receiving fentanyl and group 1 patients receiving normal 
saline. This correlated with the study done by Bisgaard et al who concluded 
that less incidence of nausea, pruritus, fatigue, overall pain following IV 
administration of dexamethasone 8 mg. There was no long term neurological 
complications in group 3 patients receiving dexamethasone.( table 16 ) 
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                                                  SUMMARY 
     After getting ethical committee approval the study was conducted in 60 
patients undergoing elective hernioplasty  belonging to ASA physical status I & 
II. The 60 patients enrolled in the study were divided into three groups.The data 
were statistically analysed , compared and discussed. The results obtained were 
summarised below: 
1. The demographic data like age, weight, height were comparable to each 
other in all the three group. 
2.  The onset of analgesia was significantly earlier in group 2 patients 
receiving fentanyl 5.075 min and the onset was delayed in 
dexamethasone receiving group 6.525 min . 
3. The duration of analgesia was significantly  prolonged in group 3 patients 
receiving  dexamethasone 373 min  when compared to group 2 patients 
receiving fentanyl  347.25 min. 
4. None of the patients in group 3 receiving dexamethasone had nausea. The 
incidence of nausea in group 1 was 3.55 % and in group 2 patients was 
20%.. 
5. None of the patients in group 1 and group 3 had pruritus but the incidence 
of pruritus in group 2 patients receiving fentanyl was 15%. 
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6. There is nil incidence of sedation in group 1 and group 3.There was more 
incidence of sedation in group 2 patients receiving fentanyl  
( 25 %.)  
7. The incidence of initial hypotension followed by epidural bolus was 10, 
15, 20 % in group 1, 2 and 3 respectively which were comparable. This 
initial hypotension was treated with fluid bolus and single dose of inj. 
Ephedrine 6 mg IV. 
8. There is nil incidence of any complications in all the study group. 
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12.    CONCLUSION 
            We conclude that epidural administration of dexamethasone – 
bupivacaine admixture resulted in better postoperative analgesia in terms of 
lower postoperative pain score, prolonged postoperative analgesia and patient 
comfort with fewer side effects when compared with the other two groups. 
           We also conclude that this epidural dexamethasone resulted in prolonged 
postoperative analgesia without any side effects like nausea, vomiting, pruritus, 
sedation except hypotension in few patients. 
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ANNEXURES 
PROFORMA 
TO COMPARE THE EFFICACY OF EPIDURAL DEXAMETHASONE 
VERSUS FENTANYL ON POSTOPERATIVE ANALGESIA 
NAME:                                                       SEX: 
AGE                                                            I.P NO 
DIAGNOSIS:                                              PROCEDURE: 
PREOPERATIVE ASSESSMENT: 
HISTORY: 
COMORBID CONDITIONS: 
H/O PREVIOUS SURGERY: 
DRUG ALLERGY: 
GENERAL EXAMINATION: 
HEIGHT:                                                      WEIGHT: 
ANAEMIA:                                                   JAUNDICE: 
PULSE RATE:                                                SPINE: 
BLOOD PRESSURE:                                     CVS- 
RS- 
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INVESTIGATIONS: 
HB-                                                                   BT,CT-  
BLOOD SUGAR-                                             BLOOD UREA- 
CREATININE-                                                 ECG- 
CXR- 
TIME ONSET LEVEL 
ACHIEVED 
VAS DURATION SIDE 
EFFECTS 
BASELINE      
10 MIN      
30 MIN      
60 MIN      
90 MIN      
120 MIN      
150 MIN      
180 MIN      
210 MIN      
240 MIN      
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SIDE EFFECTS  
NAUSEA,VOMITING  
PRURITUS  
SEDATION  
HYPOTENSION  
BRADYCARDIA  
 
INJ.EPHEDRINE (6 MG IV ) 
INJ.ATROPINE (0.6 MG IV ) 
RESCUE ANALGESIA 
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PATIENT CONSENT FORM  
 
TO COMPARE THE EFFICACY OF EPIDURAL DEXAMETHASONE 
VERSUS FENTANYL ON POSTOPERATIVE ANALGESIA IN 
PATIENTS UNDERGOING ELECTIVE HERNIOPLASTY 
Study Centre : Department of Anaesthesiology & Critical Care, Kilpauk       
Medical College.  
Participant Name :    Age :     Sex :  
I.P. No :  
 
 I ,confirm that I have understood the purpose of procedure for the above 
study. I had the opportunity to ask the question and all my questions and doubts 
have been answered to my satisfaction.  
 I have been explained about the pitfall in the procedure and the 
management of it. I have been explained about the safety, advantages and 
disadvantages of the techniques. 
 
 I understand that my participation in the study is voluntary and that I am 
free to withdraw at anytime without giving any reason.  
I understand that investigator, regulatory authorities and the ethics 
committee will not need my permission to look at my health records both in 
respect to current study and any further research that may be conducted in 
relation to it, even if I withdraw from the study.  
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 I understand that my identity will not  be revealed in any information 
released to third parties or published, unless as required under the law. I agree 
not to restrict the use of any data or results that arise from the study.  
 I hereby consent to participate in this study of “To COMPARE THE 
EFFICACY OF EPIDURAL DEXAMETHASONE VERSUS FENTANYL ON 
POSTOPERATIVE ANALGESIA” 
   
Name of the patient :   Signature / thumb impression of patient :  
 
Name of the witness :           Signature :  
 
Address :             Contact Number :  
 
Name of the Investigator :          Signature :  
 
Time :             Date :  
 
Place :  
 
 
 
 
 
 
 
 


























GROUP A O.5% BUPIVACAINE + 1 CC NS
NAME AGE ASA EPI SPACE CATHETER VOLUME ONSET OF PEAK LEVEL BROMAGE POST OP VAS @ 30 VAS @ VAS @ VAS @ VAS @ VAS @
LENGTH OF LA ANALGESIA ONSET ACHIEVED SCALE SENSORY MINUTE 1 HOUR 1 1/2 HR 2 HOURS 2 1/2 HR 3 HOUR
LEVEL
KANNAN 35                  I L2-L3 6 CM 11 CC 5 MIN 9 MIN T6 I T 10 0 0 1 1 1 3
CHINNAPAN 29 I L2-L3 6 CM 11 CC 4 MIN 30 SEC 8 MIN T6 I T 10 0 0 1 2 2 2
THANGAMAN 25 I L2-L3 5 CM 11 CC 6 MIN9 MIN 30 SEC T6 I T8 0 0 0 1 1 1
ARUN 25 I L2-L3 6 CM 11 CC  4 MIN 7 MIN T6 II T10 0 0 1 1 2 2
GOVINDRAJAN 32 I L2-L3 6 CM 11 CC6 MIN 30 SEC 8MIN T6 I T10 0 0 2 2 2 3
ARUNGIRI 36 I L2-L3 6 CM 11 CC 7 MIN9 MIN 30 SEC T6 I T10 0 0 1 1 2 2
KATHIRVEL 30 I L2-L3 6 CM 11 CC 5 1/2 MIN 10 MIN T6 I T10 0 0 1 1 2 2
ULAGAPPAN 37 I L2-L3 6 CM 11 CC 4 MIN   8 MIN T6 II T 10 0 0 2 2 3 3
SANTOSH 31 I L2-L3 6 CM 11 CC 6 MIN 9 MIN T6 I T10 0 0 1 2 2 2
KUMARAN 29 I L2-L3 6 CM 11 CC 5 MIN8 MIN 30 SEC T6 I T8 0 0 1 1 2 2
MOHANRAJ 26 I L2-L3 6 CM 11 CC 3 MIN 7 MIN T6 I T10 0 0 2 2 2 4
SUBRAMANI 33 I L2-L3 6 CM 11 CC 4 MIN 9 MIN T6 I T10 0 0 1 2 2 2
MUTHUVEL 28 I L2-L3 6 CM  11 CC 5 MIN 7 MIN T6 I T10 0 0 2 2 2 3
CHENGAPPAN 31 I L3-L4 6 CM 11 CC 5 MIN9 MIN 30 SEC T6 I T10 0 0 2 2 2 2
CHARLES 36 I L2-L3 6  CM 11CC 7 MIN 9 MIN T5 I T10 0 0 1 1 2 2
DHANRAJ 27 I L2-L3 6 CM 11 CC 4 1/2 MIN 7 MIN T6 I T10 0 0 0 1 2 2
SUKUMAR 40 II L2-L3 6 CM 11 CC 5 MIN8 MIN 30 SEC T6 I T10 0 0 2 2 2 2
JEYAKUMAR 32 I L2-L3 6 CM 11 CC 6 MIN 9 MIN T6 I T10 0 0 0 1 2 2
VENKETESAN 28 I L2-L3 6 CM 11 CC 5 MIN 9 MIN T6 I T10 0 0 2 2 2 3
THIRUMAL 33 I L2-L3 6 CM 11 CC3 MIN 30 SEC 6 MIN T6 I T10 0 0 2 2 2 2
GROUP B - 0.5% BUPIVACAINE + FENTANYL 50 MICROGRAM
NATRAJAN 26 I L2-L3 6 CM 11 CC 6 MIN 10 MIN T6 II T10 0 0 0 1 1 2
BOOPATHY 23 I L2-L3 5 CM 11 CC 5 MIN8 MIN 30 SEC T6 II T8 0 0 0 1 1 1
ABBAS GANI 28 I L2-L3 6 CM 11 CC 8 MIN 10 MIN T6 II T10 0 0 0 1 1 1
NEELAMEGALAI 28 I L2-L3 5 CM 11 CC 9 MIN 12 MIN T6 II T8 0 0 0 0 1 1
SENTHILKUMAR 24 I L2-L3 6 CM 11 CC 10 MIN 12 MIN T6 I T8 0 0 0 0 1 1
MURALIDARAN 42 II L2-L3 6 CM 11 CC 5 MIN 8 MIN   T6 I T10 0 0 0 0 1 1
JOTHI 40 I L2-L3 5 CM 11 CC4 MIN 30 SEC 7 MIN T6 II T10 0 0 0 0 1 1
SEKAR 48 II L2-L3 5 CM 11 CC 3 1/2 MIN 6 MIN T6 I T10 0 0 0 0 1 1
SRINATH 29 I L2-L3 5 CM 11 CC7 MIN 30 SEC 10 MIN T6 II T10 0 0 0 0 0 1
RAMAN 36 I L2-L3 6 CM 11 CC 6 MIN 9 MIN T6 I T8 0 0 0 1 1 1
KESAVAN 30 I L2-L3 6 CM 11 CC 8 MIN 10 MIN T6 I T10 0 0 0 1 1 1
BASAVAPPA 42 II L2-L3 6 CM 11 CC 7 MIN  9 MIN T8 I T10 0 0 0 2 2 2
VELAVAN 30 I L2-L3 6 CM 11 CC6 MIN 30 SEC 10 MIN T6 I T10 0 0 0 0 2 2
RAJA 32 I L2-L3 6 CM 11 CC 5 MIN 9 MIN  T6 I T10 0 0 0 2 2 2
PARTHASARATHY 28 I L2-L3 6 CM 11 CC 7 MIN 10 MIN T6 I T10 0 0 0 2 2 2
KUMARESAN 27 I L2-L3 6 CM 11 CC5 MIN 30 SEC 8 MIN T6 II T10 0 0 0 2 2 2
CHARLES 30 I L3-L4 6 CM 11 CC 7 MIN 9 MIN T6 I T10 0 0 0 0 2 2
RAGAVAN 32 I L2-L3 6 CM 11 CC 6 MIN 11 MIN T6 I T10 0 0 0 2 2 2
CHINNASAMY 28 I L2-L3 6 CM 11 CC 6 MIN 9 MIN T6 I T10 0 0 0 0 2 2
ULAGANATHAN 36 II L2-L3 6 CM 11 CC 8 MIN 10 MIN T6 II T10 0 0 0 0 2 2
GROUP C - 0.5%  BUPIVACAINE + 4 MG DEXAMETHASONE
RAVINDRAN 34 I L2-L3 6 CM 11 CC4 MIN 30 SEC 6 MIN T6 I T8 0 0 0 0 1 2
MURUGAN 45 II L2-L3 5 CM 11 CC 5 MIN 8 MIN 30 SEC T6 I T8 0 0 0 0 0 2
BALARAM 22 I L2-L3 6 CM 11 CC 7 MIN 10 MIN T6 I T10 0 0 0 1 1 1
RAMACHANDRA SHARMA29 I L2-L3 6 CM 11 CC5 MIN 30 SEC 11 MIN T8 II T10 0 0 0 2 2 2
RAVEENDRAN 43 I L2-L3 5 CM 11 CC 3 MIN 8 MIN T6 I T10 0 0 0 0 0 2
KUMARESAN 32 I L2-L3 6 CM  11 CC 6 MIN 8 MIN T6 I T10 0 0 0 0 1
SIVAKUMAR 30 I L2-L3 6 CM 11 CC 6 MIN 8 MIN T6 II T8 0 0 0 0 1 2
MAHESHWARAN 28 I L2-L3 6 CM 11 CC 4 MIN  8 MIN T6 I T10 0 0 0 0 1 1
APPADURAI 25 I L2-L3 6 CM 11 CC3 MIN 30 SEC 7 MIN T6 I T10 0 0 0 1 2 2
SIVANESAN 33 I L2-L3 5 CM 11 CC 7 MIN 10 MIN T8 II T10 0 0 0 1 1 1
GIRIDARAN 32 I L2-L3 6 CM 11 CC 6 MIN9 MIN 30 SEC T6 II T10 0 0 0 2 2 2
BASKAR 28 I L2-L3 6 CM 11 CC 5 MIN 10 MIN T6 II T10 0 0 0 2 2 3
KANI 40 II L2-L3 6 CM 11 CC 4 MIN 7 MIN T6 II T10 0 0 0 0 0 2
SENTHILVEL 36 I L2-L3 6 CM 11 CC5 MIN 30 SEC 9 MIN   T6 I T8 0 0 0 2 2 2
GNANASEKAR 27 I L2-L3 6 CM 11 CC3 MIN 30 SEC 7 MIN T6 I T10 0 0 0 1 1 2
ALAGESAN 38 I L2-L3 5 CM 11 CC 4 MIN  8 MIN  T6 I T10 0 0 0 1 1 1
SANTHOSH 25 I L2-L3 6 CM 11 CC 6 MIN11 MIN 30 SEC T6 II T10 0 0 0 1 1 1
MOHANRAJ 30 I L2-L3 6 CM 11 CC 8 MIN 11 MIN T6 I T10 0 0 0 1 1 1
SURENDRAN 24 I L2-L3 6 CM 11 CC 5 MIN8 MIN 30 SEC T8 I T10 0 0 1 2 2 2
AFSAL 32 I L2-L3 6 CM 11 CC7 MIN 30 SEC 10 MIN T6 I T10 0 0 0 1 2 2
VAS @ VAS @ VAS @ VAS @ VAS @ VAS @ VAS @ VAS @ VAS @ VAS @ BRADY HYPO NAUSEA PRURITUS DURATION
3 1/2 HR 4 HOURS 4 1/2 HR 5 HOUR 5 1/2 HR 6 HOUR 6 1/2 HR 7 HOUR 7 1/2 HR 8 HOUR CARDIA TENSION VOMITING OF
ANALGESIA
3 4          + 250 MIN
3 3 4 275 MIN
2 2 3 4 300 MIN
4 210 MIN
4 240 MIN
2 3 3 4 300 MIN
3 3 4 270 MIN
4 210 MIN
3 4 220 MIN
2 3 4 260 MIN
180 MIN
3 3 3 4 306 MIN
3 4 230 MIN
3 3 4 250 MIN
3 3 4 270 MIN
4 200 MIN
2 4 + 280 MIN
3 3 3 4 320 MIN
3 4 250 MIN
2 3 3 3 4 300 MIN
2 3 4 270 MIN
1 2 2 2 3 3 4 400 MIN
2 2 2 3 3 4 360 MIN
2 2 2 2 3 3 3 4 410 MIN
2 2 2 3 3 4 + 370 MIN
1 2 2 3 3 4 360 MIN
1 2 2 2 3 4 320 MIN
1 1 3 3 3 3 4 360 MIN
1 2 2 2 2 3 3 4 450 MIN
2 2 3 3 4 + 300 MIN
1 3 3 3 3 4 350 MIN
3 3 4 4 280 MIN
2 2 2 3 3 4 + 300 MIN
2 3 3 3 4 350 MIN
2 2 4 320 MIN
2 3 3 3 4 340 MIN
3 3 3 3 3 4 380 MIN
2 3 3 3 3 3 4 + + 365 MIN
2 2 3 3 3 3 3 4 300 MIN
2 3 3 3 3 3 4 340 MIN
3 3 3 4          + 310 MIN
2 2 2 2 3 4 4 380 MIN
3 3 4 270 MIN
2 2 3 3 3 3 3 4 430 MIN
2 2 2 3 4 330 MIN
2 2 3 3 3 4 360 MIN
2 2 3 3 4 330 MIN
2 2 4 290 MIN
2 2 3 3 3 3 4 380 MIN
2 2 2 3 3 4 320 MIN
2 3 3 4 300 MIN
3 4 4 280 MIN
2 2 3 3 3 3 3 4 423 MIN
2 3 3 3 4 330 MIN
2 2 3 3 3 4 375 MIN
2 2 3 3 4 300 MIN
1 2 2 2 2 2 3 3 4 480 MIN
2 2 2 2 3 3 4 395 MIN
3 3 3 3 4 360 MIN
2 3 3 4 290 MIN
